PharmaPatents Timely Insight on Emerging Legal Developments

Tag Archives: 102(e)

The Disharmonious Loss Of The Hilmer Doctrine

Posted in Patent Reform

One of the many changes included in the Leahy-Smith America Invents Act relates to the date that a U.S. patent application is effective as prior art. While eliminating the Hilmer doctrine and giving prior art effect to U.S. patent applications as of their foreign priority dates might seem to be a step towards international harmonization, it actually may widen the gulf between the U.S. and the rest of world.

Continue reading this entry